S. Percy Ivy

Combination cediranib and olaparib versus olaparib alone for women with recurrent platinum-sensitive ovarian cancer: a randomised phase 2 study

Joyce F. Liu, William T. Barry, Michael J. Birrer et al. · The Lancet Oncology · 2014 · 578 citations · Full text

Combination Cediranib, Medicine, Olaparib Versus Olaparib +9

Initial Assessment, Surveillance, and Management of Blood Pressure in Patients Receiving Vascular Endothelial Growth Factor Signaling Pathway Inhibitors

Michael L. Maitland, George L. Bakris, Henry R. Black et al. · JNCI Journal of the National Cancer Institute · 2010 · 404 citations · Full text

Hypertension, Cardiovascular Pharmacology, Pharmacotherapy +23

Design Issues of Randomized Phase II Trials and a Proposal for Phase II Screening Trials

Edward L. Korn, Boris Freidlin, Sally Hunsberger et al. · Journal of Clinical Oncology · 2005 · 395 citations

Improved tumor oxygenation and survival in glioblastoma patients who show increased blood perfusion after cediranib and chemoradiation

Tracy T. Batchelor, Elizabeth R. Gerstner, Kyrre E. Emblem et al. · Proceedings of the National Academy of Sciences · 2013 · 335 citations · Full text

Tumor Innervation, Blood Perfusion, High-grade Gliomas +22

Cediranib for Metastatic Alveolar Soft Part Sarcoma

Shivaani Kummar, Deborah Allen, Anne Monks et al. · Journal of Clinical Oncology · 2013 · 217 citations